Radiomics of Prostate Cancer (PET)

One of our ongoing efforts is to perform radiomics (texture/heterogeneity quantification) for the exciting prostate cancer tracer, PyL. Developed by the group of Dr. Martin Pomper, PyL (a PSMA-targeted PET imaging agent; see video below) is now licensed to Progenics which works closely with our division to further establish clinical use of this tracer.

One thought on “Radiomics of Prostate Cancer (PET)

  1. Pingback: Radiomics of Prostate Cancer (PET) — Rahmim Lab | Qualia Radiomics

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s